Key result
Intravenous administration of ANP in rats decreased renal net interstitial pressure and decreased tubuloglomerular feedback sensitivity, increasing the tubular flow rate for half-maximal Psf drop from 18.5 to 25.7 nl/min.
Answers are grounded in this paper and cite their sources.
No direct clinical implications; leaves open whether interstitial pressure mediates ANP effects on TGF in humans.
Atrial natriuretic peptide (ANP), injected at physiological concentrations, is known to induce both natriuresis and diuresis. It has been suggested by some investigators that these changes result from an increasing glomerular filtration rate (GFR), but others have been unable to demonstrate an increased GFR. The tubuloglomerular feedback (TGF) mechanism is an important regulator of GFR, and the sensitivity of TGF is decreased during ANP administration. Furthermore, resetting of TGF is, in most instances, related to changes in renal interstitial hydrostatic and oncotic pressures. It is also known that ANP may increase capillary permeability which may change renal interstitial pressure. The present study was performed to examine renal interstitial pressures and the TGF mechanism during ANP infusion. In accordance with previous studies, TGF sensitivity was found to be decreased. The tubular flow rate which elicited half the maximal drop in stop-flow pressure (Psf) was increased from 18.5 to 25.7 nl min-1. In contrast, ANP infusion resulted in a decreased interstitial hydrostatic pressure and an increased interstitial oncotic pressure. From previous experiments, such changes in interstitial pressures would be expected to increase TGF sensitivity. The changes in interstitial pressure cannot, therefore, directly explain the resetting of the feedback mechanism. In conclusion, the present paper shows a decreased renal net interstitial pressure after intravenous administration of ANP.
No takes yet. Share an insight, caveat, or question.
Morsing et al. (1992) studied this question. Atrial natriuretic peptide (ANP) was evaluated on Tubular flow rate eliciting half the maximal drop in stop-flow pressure (Psf). Intravenous administration of ANP in rats decreased renal net interstitial pressure and decreased tubuloglomerular feedback sensitivity, increasing the tubular flow rate for half-maximal Psf drop from 18.5 to 25.7 nl/min.
Synapse has enriched 10 related papers. Consider them for comparative context: